Evidence map›Paper›PMID 27807816›Full record

ArticleAdvances in therapy2017

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients.

Ryuji Morishige, Hiroshi Nakajima, Kazutake Yoshizawa, Jörg Mahlich, Rosarin Sruamsiri

Open access · hybridAbstract read
In one paragraph

Article in Advances in therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Socio-economic differences in patient participation behaviours in doctor-patient interactions-A systematic mapping review of the literature.Health expectations : an international journal of public participation in health care and health policy · 2019
    Pooled it
  2. Discordance between observer and patient-reported shared decision-making in inflammatory bowel disease: A multicenter cross-sectional study.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Shared Decision Making in Gastroenterology: Challenges and Opportunities.Mayo Clinic proceedings. Innovations, quality & outcomes · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ryuji MorishigeMedical Affairs, Janssen Pharmaceutical K.K., Tokyo, Japan.
Hiroshi NakajimaMedical Affairs, Janssen Pharmaceutical K.K., Tokyo, Japan.
Kazutake YoshizawaMedical Affairs, Janssen Pharmaceutical K.K., Tokyo, Japan.
Jörg MahlichHealth Economics, Janssen Pharmaceutical K.K., Tokyo, Japan. jmahlich@ITS.JNJ.com.
Rosarin SruamsiriHealth Economics, Janssen Pharmaceutical K.K., Tokyo, Japan.
Naresuan University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRecent studies have indicated that patients are showing increased interest in playing a larger role in making decisions regarding their medical treatment. Inflammatory bowel disease (IBD) is a chronic disease that manifests either as Crohn's disease (CD) or ulcerative colitis (UC). IBD treatment is multifaceted and dependent on patient-specific factors. The selection of treatment options is mostly driven by physicians, and it is unclear to what degree patients are involved in shared decision-making (SDM). The objective of the current study is to assess preferences among Japanese patients with IBD in regard to SDM during their treatment for IBD.

methodsA nationwide web-based survey was performed in Japan during February 2016. The patients were asked for their basic clinical characteristics, socioeconomic status, medical history, treatment details, and preferences regarding SDM in IBD treatment. Differences were analyzed by chi-square, t tests, a multiple regression analysis, and ordered logistic regression analysis.

resultsIn response to the screening survey, a total of 1068 Japanese nationals met the inclusion criteria for this study of being patients diagnosed with IBD who are currently receiving treatment. Of these, 235 had CD and 800 UC; 33 were not specified. Overall, the majority of these patients felt that SDM was very important. Furthermore, interest in SDM was strongly associated with certain disease comorbidities, surgical history, and current treatment, although there were some differences in the results between CD and UC.

conclusionThe present study found that the majority of IBD patients in Japan wanted to have a role in their treatment plan. The results indicate that the patient's preference in regard to SDM was driven by their perception of the severity or progression of their disease.

fundingJanssen Pharmaceuticals.

Indexed as

Decision MakingAdultAgedAged, 80 and overAsian PeopleColitis, UlcerativeCrohn DiseaseFemaleHumansInflammatory Bowel DiseasesJapanMaleMiddle AgedPatient PreferenceSurveys and QuestionnairesYoung AdultGastroenterologyInflammatory bowel diseaseJapanPatient preferencesShared decision making

Identifiers

PMID27807816
PMCPMC5126200
OpenAlexW2546672766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.